Bandim Health Project, INDEPTH Network, Bissau, Guinea-Bissau
Dept of Infectious Diseases, Aarhus University Hospital, Aarhus, Denmark.
Eur Respir J. 2021 Oct 21;58(4). doi: 10.1183/13993003.00090-2021. Print 2021 Oct.
The World Health Organization (WHO) recommends active case-finding (ACF) of tuberculosis (TB) in certain high-risk groups; however, more evidence is needed to elucidate the scope of ACF beyond the current recommendations. In this study we aimed to systematically review yields (the prevalence of active TB) of studies on ACF in general populations and at-risk groups.
A literature search in PubMed, Embase and the Cochrane Central Library (CENTRAL) was performed for studies concluded after 31 December 1999 and published before 1 September 2020. Screening yields were estimated and yield/prevalence ratios (ratio between yield of study and WHO estimated prevalence of TB) were calculated to assess which groups might especially benefit from ACF. Finally, risk of bias was assessed and heterogeneity was investigated using meta-regression and sensitivity analyses.
We included 197 studies, with a total of 12 372 530 screened and 53 158 cases found. Yields were high among drug users, close contacts, the poor and marginalised, people living with HIV, and prison inmates across incidence strata, and estimated yield/prevalence ratios in screenings of general populations tended to be >1 with an overall ratio of 1.4 and ranging between 1.0 and 1.5. Sensitivity analyses suggested that inclusion of studies at high risk of bias contributed to underestimation of yields.
Despite many studies using insensitive screening methods, these results suggest that more at-risk groups should be considered for inclusion in future screening recommendations and that screening of general populations may outperform current case-finding practices, providing evidence for extending ACF beyond the current recommendations.
世界卫生组织(WHO)建议对某些高危人群进行结核病(TB)主动病例发现(ACF);然而,需要更多的证据来阐明超出当前建议范围的 ACF 范围。在这项研究中,我们旨在系统地回顾一般人群和高危人群中 ACF 的研究的收益(活动性 TB 的患病率)。
对 1999 年 12 月 31 日以后和 2020 年 9 月 1 日以前发表的文献进行了 PubMed、Embase 和 Cochrane 中央图书馆(CENTRAL)的文献检索。估计筛查收益,并计算收益/患病率比(研究收益与 WHO 估计的 TB 患病率之比),以评估哪些人群可能特别受益于 ACF。最后,使用 meta 回归和敏感性分析评估偏倚风险和异质性。
我们纳入了 197 项研究,共筛查了 12372530 人,发现了 53158 例病例。在各个发病阶层中,药物使用者、密切接触者、贫困人口和边缘人群、HIV 感染者和囚犯的收益较高,一般人群筛查的估计收益/患病率比往往>1,总体比值为 1.4,范围在 1.0 到 1.5 之间。敏感性分析表明,纳入高偏倚风险的研究导致对收益的低估。
尽管许多研究使用了不敏感的筛查方法,但这些结果表明,应该考虑将更多的高危人群纳入未来的筛查建议中,并且一般人群的筛查可能优于当前的病例发现实践,为扩大 ACF 范围提供了证据,超出了当前的建议。